Cambridge, MA, United States of America

Shigeru Komaba

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Dynamicure Biotechnology LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigeru Komaba. Retrieved from https://idiyas.com/inventor/shigeru-komaba

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shigeru Komaba: Innovator in Biotechnology

Introduction

Shigeru Komaba is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly through his innovative work at Dynamicure Biotechnology LLC. His expertise and dedication have led to the development of groundbreaking technologies.

Latest Patents

Shigeru Komaba holds a patent titled "ANTI-CD93 CONSTRUCTS AND USES THEREOF." This patent reflects his commitment to advancing medical science and improving therapeutic options.

Career Highlights

Throughout his career, Shigeru has focused on creating solutions that address critical health challenges. His work at Dynamicure Biotechnology LLC has positioned him as a key player in the biotechnology sector.

Collaborations

Shigeru has collaborated with talented individuals such as Zhinan Xia and Zirong Chen. These partnerships have fostered innovation and contributed to the success of their projects.

Conclusion

Shigeru Komaba is a distinguished inventor whose work in biotechnology continues to impact the field positively. His patent and collaborations highlight his dedication to advancing medical research and technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…